MeSH tree: D12.644.276
Drinking tomato-soy juice loaded with compounds shown in animal studies to promote health lowered pro-inflammatory proteins in healthy adults with obesity after four weeks, a new study found.
May 26, 2026
0
7
The inaugural Enhanced Games are underway in Las Vegas and are set to be a unique spectacle that promotes drug-induced "enhancement." The International Olympic Committee has condemned the event as a way to "destroy any concept ...
May 25, 2026
0
6
A new study has identified hepatitis A virus cellular receptor 1 (HAVCR1) as a biomarker that could make it easier to diagnose rare but aggressive forms of brain and eye cancer earlier and with fewer invasive tests.
May 22, 2026
0
5
When stress affects the gut, the stomach tightens, digestion slows. For some, these symptoms resolve quickly. For others—particularly people with constipation-predominant irritable bowel syndrome (IBS-C) and related conditions—they ...
May 20, 2026
0
28
Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key finding from a University of Bristol-led pilot randomized controlled clinical trial, published in JAMA ...
May 20, 2026
0
21
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new cytokine-armored CAR-T cell therapy that helps the immune system better attack aggressive brain tumors in mice while reducing dangerous ...
May 20, 2026
0
9
What if the very structures we thought were destroying the brain are actually trying to save it? A new study reveals that protein clumps, long considered toxic markers of diseases like Huntington's, act as a vital "quarantine" ...
May 19, 2026
0
13
Barrier organs that form boundaries between the body and the outside environment, such as the lungs, skin, and intestines, face a difficult balancing act. They must respond quickly to threats such as infection, but they also ...
May 16, 2026
0
11
Mayo Clinic researchers have identified an immune-regulating molecule that may help explain why some patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, do not respond to commonly ...
May 13, 2026
0
35
Developing effective immunotherapies for acute myeloid leukemia (AML) has long been hampered by a critical challenge: Therapy directed at killing the leukemia cells may also harm the body's ability to make new, healthy blood ...
May 12, 2026
0
14
